Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis Location: Maryland 13 trials found
New Search
Filter
Trial Phase
Study Type
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
PHASE3INTERVENTIONAL Palo Alto, California +4 more
RECRUITING
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Smoldering Inflammation in MS
N/AOBSERVATIONAL St Louis, Missouri
RECRUITING
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
PHASE2INTERVENTIONAL Boston, Massachusetts +4 more
RECRUITING
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Pheonix, Arizona +4 more
RECRUITING
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
N/AOBSERVATIONAL St Louis, Missouri
RECRUITING
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
PHASE1, PHASE2INTERVENTIONAL Kansas City, Kansas +1 more
RECRUITING
Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
N/AOBSERVATIONAL St Louis, Missouri
RECRUITING
Filter Trials
Trial Phase
Study Type